Cargando…
Post-Stroke Spastic Movement Disorder and Botulinum Toxin A Therapy: Early Detection And Early Injection
Post-stroke spastic movement disorder (PS-SMD) develops in up to 40% of stroke survivors after a first ever stroke within the first year. Chronic PS-SMD is often associated with severe disabilities and complications, emphasizing the importance of its early recognition and early adequate management....
Autores principales: | Wissel, Jörg, Kivi, Anatol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Academy of Rehabilitation Medicine
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620487/ https://www.ncbi.nlm.nih.gov/pubmed/37907224 http://dx.doi.org/10.5535/arm.23108 |
Ejemplares similares
-
Early Botulinum Toxin Type A Injection for Post-Stroke Spasticity: A Longitudinal Cohort Study
por: Picelli, Alessandro, et al.
Publicado: (2021) -
EARLY BRAIN IMAGING PREDICTORS OF POST-STROKE SPASTICITY
por: RI, Songjin, et al.
Publicado: (2021) -
Guidelines for the use of botulinum toxin in movement disorders and spasticity
por: Jabeen, Afshan, et al.
Publicado: (2011) -
The Safety and Effect of Local Botulinumtoxin A Injections for Long-Term Management of Chronic Pain in Post-Herpetic Neuralgia: Literature Review and Cases Report Treated with Incobotulinumtoxin A
por: Ri, Songjin, et al.
Publicado: (2021) -
A Literature Review on the Efficacy and Safety of Botulinum Toxin: An Injection in Post-Stroke Spasticity
por: Ghasemi, Majid, et al.
Publicado: (2013)